Radiochemical and radiopharmacological properties of Pirocarbotrat and other labeled charcoal dispersions: Comparative studies in rats with NMU- induced mammary tumors

Nuclear Medicine and Biology

Volumn 25, Issue 3, 1998, Pages 305-311

  Zubillaga, M B ^a   Boccio, J R ^a   Nicolini, J O ^b   Ughetti, R ^b   Lanari, E ^c   Caro, R A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^c Nuclear Medicine Department   (Argentina)

Author keywords

32P; Beta therapy; Brachytherapy; Radiotherapy; Rats; Tumor

Indexed keywords

CHARCOAL; CHROMIUM PHOSPHATE; PHOSPHATE; PHOSPHORUS 32; PIROCARBOTRAT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BREAST TUMOR; CANCER REGRESSION; DRUG ELIMINATION; FEMALE; ISOTOPE LABELING; MOUSE; NONHUMAN; RADIATION DEPTH DOSE; RADIOISOTOPE THERAPY; TREATMENT OUTCOME;

ADENOCARCINOMA; ANIMALS; CHARCOAL; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLIC CLEARANCE RATE; METHYLNITROSOUREA; PHOSPHATES; PHOSPHORUS RADIOISOTOPES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0032053548     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00205-9     Document Type: Article

References (30)

1. 1. Agresti A. (1990) Categorical Data Analysis. John Wiley, New York.
2. 2. Anghileri L. J. (1968) Studies on colloidal chromic phosphate: An improved method of preparation and in situ precipitation by injection of papain. Int. J. Appl. Radiat. Isot. 19, 415-420.
3. 32P-chromic phosphate. J. Nucl. Med. 9, 562-566.
4. 32) for local irradiation of the central nervous system. Int. J. Appl. Radiat. Isot. 18, 97-100.
5. 5. Bergqvist L., Sundberg R., Rydén S. and Strand S. E. (1987) The "critical colloid dose" in studies of reticuloendothelial function. J. Nucl. Med. 28, 1424-1429.
6. 6. Brain J. D. (1992) Mechanisms, measurement and significance of lung macrophage function. Environ. Health Perspect. 97, 5-10.
7. 7. Caro R. A., Nicolini J. O. and Radicella R. (1968) Preparation and biological behavior of radiogold colloids stabilized with polyvinylpyrrolidone (PVP). Int. J. Appl. Radiat. Isot. 19, 547-550.
8. 8. Caro R. A., Ciscato V. A. and Radicella R. (1970) Kinetics of the phagocytosis of radiogold colloids by the reticuloendothelial system in the rat. Int. J. Appl. Radiat. Isot. 21, 405-414.
9. 9. Cingolani H. and Houssay A. (1989) Fisiología Humana, 6th ed. El Ateneo, Buenos Aires, Argentina.
10. 10. Cohen Y., Ingrand J. and Caro R. A. (1968) Kinetics of disappearance of gelatin protected radiogold colloids from the blood stream. Int. J. Appl. Radiat. Isot. 19, 703-705.
11. 11. Crusinberry R. A., Kramolowsky E. V. and Loening S. A. (1987) Percutaneous transperineal placement of gold-198 seeds for treatment of carcinoma of the prostate. Prostate 11, 59-67.
12. 12. DeCamp M. M., Warner, A. E., Molina R. M. and Brain J. D. (1992) Hepatic versus pulmonary uptake of particles injected into the portal circulation in sheep: Endotoxin escapes hepatic clearance causing pulmonary inflammation. Am. Rev. Respir. Dis. 146, 224-231.
13. 90Y microspheres. Nucl. Med. Biol. 14, 233-242.
14. 14. Gullino P. M., Pettigrew H. M. and Grantham F. H. (1975) N-nitrosomethylurea as mammary gland carcinogen in rats. J. Natl. Cancer Inst. 54, 401-404.
15. 90Y: Microspheres to tumor cells by an externally applied magnetic field -preliminary in vitro and in vivo results. Nucl. Med. Biol. 22, 147-155.
16. 16. Harbert J. C. (1987) Nuclear Medicine Therapy. Thieme Medical Publishers, New York.
17. 17. Kaye K. W., Olson D. J., Lightner D. J., and Thomas Payne J. (1992) Improved technique for prostate seed implantation: Combined ultrasound and fluoroscopic guidance. J. Endourol. 6, 61-66.
18. 18. Loening S. A. and Rosenberg S. J. (1987) Percutaneous placement of radioactive gold seeds in localized prostatic carcinoma. Urology 29, 250-252.
19. 19. Mitta A. and Robles A. M. (1986) Quality Control of Radiopharmaceuticals. ALABISMN, Montevideo, Uruguay.
20. 20. Porter A. T., Blasko J. C., Grimm P. D., Reddy S. M. and Ragde H. (1995) Brachytherapy for prostate cancer. CA Cancer J. Clin. 45, 165-178.
21. 21. Priestly J. B. Jr. and Breyer D. C. (1992) Guided brachytherapy for treatment of confined prostate cancer. Urology 40, 27-32.
22. 22. Rivera E. S., Andraede N., Martin G., Melito G., Cricco G., Mohamad N., Davio C., Caro R. and Bergoc R. M. (1994) Induction of mammary tumors in rat by intraperitoneal injection of NMU: Histopathology and estral cycle influence. Cancer Lett. 86, 223-228.
23. 23. Silberstein E. B., Elgazzar A. H. and Kapilivsky A. (1992) Phosphorus-32 radiopharmaceuticals for the treatment of painful osseous metastases. Semin. Nucl. Med. 22, 17-27.
24. 24. Sokal R. R. and Rohlf F. J. (1981) Biometry. Freeman & Company, New York.
25. 25. Thompson P. N., Cho E., Blumenstock F. A., Shah D. M. and Saba T. M. (1992) Liver and spleen phagocytic depression after peripheral ischemia and reperfusion. Am. J. Surg. 164, 248-253.
26. 32P labeled ion exchange resin microspheres for radiation therapy of hepatic neoplasms. Int. J. Appl. Radait. Isot. 14, 1343-1350.
27. 32P]chromic phosphate for treatment of solid tumors. Acta Physiol. Pharmacol. Ther. Lat. 46, 103-110.
28. 32P]phosphate in treatment of solid tumors. Nucl. Med. Biol. 23, 907-910.
29. 29. Zubillaga M. B., Boccio J. R., Nicolini J. O., Ughetti R., Lanari E. and Caro R. (in press) Pirocarbotrat, a new radiopharmaceutical for the treatment of solid tumors: Comparative studies in N-nitrosomethylurea-induced rat mammary tumors. Nucl. Med. Biol.
30. 30. Zubillaga M. B., Boccio J. R., Nicolini J. O., Ughetti R., Lanari E. and Caro R. (in press) Braquiterapia de tumores sólidos: Uso del fosfato crómico coloidal. Acta Physiol. Pharmacol. Ther. Lat.